Search

Your search keyword '"Zhang,Zhi-Yuan"' showing total 434 results

Search Constraints

Start Over You searched for: Author "Zhang,Zhi-Yuan" Remove constraint Author: "Zhang,Zhi-Yuan" Database Unpaywall Remove constraint Database: Unpaywall
434 results on '"Zhang,Zhi-Yuan"'

Search Results

12. Glucose fluctuations aggravated the late sodium current induced ventricular arrhythmias via the activation of ROS/CaMKII pathway

20. Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway

23. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer

28. Supplementary material 3 from: Zhang Z-Y, Li X, Chen W-H, Liang J-D, Han Y-F (2023) Culturable fungi from urban soils in China II, with the description of 18 novel species in Ascomycota (Dothideomycetes, Eurotiomycetes, Leotiomycetes and Sordariomycetes). MycoKeys 98: 167-220. https://doi.org/10.3897/mycokeys.98.102816

29. Supplementary material 2 from: Zhang Z-Y, Li X, Chen W-H, Liang J-D, Han Y-F (2023) Culturable fungi from urban soils in China II, with the description of 18 novel species in Ascomycota (Dothideomycetes, Eurotiomycetes, Leotiomycetes and Sordariomycetes). MycoKeys 98: 167-220. https://doi.org/10.3897/mycokeys.98.102816

30. Supplementary material 1 from: Zhang Z-Y, Li X, Chen W-H, Liang J-D, Han Y-F (2023) Culturable fungi from urban soils in China II, with the description of 18 novel species in Ascomycota (Dothideomycetes, Eurotiomycetes, Leotiomycetes and Sordariomycetes). MycoKeys 98: 167-220. https://doi.org/10.3897/mycokeys.98.102816

37. Integrated Omic Analysis of Human Plasma Metabolites and Microbiota in a Hypertension Cohort

39. Supplementary Figure 3 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

40. Supplementary Figure 2 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

41. Supplementary Figure 4 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

42. Supplementary Figure 2 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

43. Supplementary Figure 4 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

44. Data from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

45. Supplementary Tables 1 - 5 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

46. Data from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

47. Supplementary Figure 1 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

48. Supplementary Figure 3 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

49. Supplementary Tables 1 - 5 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

50. Supplementary Figure 1 from Elevated Cyclin D1 Expression Is Predictive for a Benefit from TPF Induction Chemotherapy in Oral Squamous Cell Carcinoma Patients with Advanced Nodal Disease

Catalog

Books, media, physical & digital resources